Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01942824 · ClinicalTrials.gov registry record · NA
Adult Influenza Vaccination Text Message Reminders
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 7,250
- Enrollment target
NCT01942824 is a NA study that has completed, run by Columbia University. The registered enrollment target is 7,250 participants.
The verdict
NCT01942824, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,250 participants
- Enrollment target
Study Summary
Influenza infection leads to on average 24,0000 deaths and 150,000 hospitalizations annually. While vaccination is the cornerstone of preventing influenza infection, vaccination coverage in adults is low with only 35% vaccinated by end of November. Latino adults have the lowest coverage rates. Text message reminders have been used successfully for improving influenza vaccination for children. This study will assess the use of text messaging to improve influenza vaccination coverage rates in a largely minority, publicly insured adult population.
Interventions
- BEHAVIORAL Text Messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,250 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01942824
The ClinicalTrials.gov registry entry for NCT01942824 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7,250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Text Messages is the first listed.
NCT01942824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01942824 about?
NCT01942824 is a clinical study titled "Adult Influenza Vaccination Text Message Reminders". Influenza infection leads to on average 24,0000 deaths and 150,000 hospitalizations annually. While vaccination is the cornerstone of preventing influenza infection, vaccination coverage in adults is low with only 35% vaccinated by end of November. Latino adults have the lowest coverage rates. Text ...
What is the current status of trial NCT01942824?
This trial is currently completed. It is a NA study. The enrollment target is 7,250 participants. The study started on 2013-09. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01942824?
The interventions under investigation include: Text Messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT01942824?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.